AnBogen Therapeutics

Taiwan
Nankang, Taipei, Taiwan
+886 2 8979 8616 ★

Company profile

AnBogen Therapeutics company profile

Anbogen is a clinical-stage biotechnology company dedicated to developing precision anti-cancer drugs that hold the/promise of curing cancers and/or improving the lives of cancer patients worldwide.

Business identity

Contact email
[email protected]
Phone number
+886 2 8979 8616
Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$1K+
Founded
2019-01-01

Headquarters

Headquarters
Nankang, Taipei, Taiwan
Postal code
11571
Country code
TW
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$19.8M
Last funding
Series A / $7.3M / 2024-07-01
Last equity funding
Series A / $7.3M
Investors
5
Lead investors
2
Articles
10

Founders and investors

Lead investors

China Development Industrial Bank (CDIB)KGI Venture Capital

Investors

China Development Industrial Bank (CDIB)KGI Venture CapitalMaxpro VenturesNational Development Fund of Taiwan GovernmentTaiAn Technologies

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.